A prospective study to determine the clinical utility of pharmacogenetic testing of veterans with treatment-resistant depression.
Michael J McCarthyYucui ChenAnna DemodenaSusan G LeckbandEileen FischerShahrokh GolshanTrisha SuppesJohn R KelsoePublished in: Journal of psychopharmacology (Oxford, England) (2021)
The data reveal possible group differences in the utility of PGX testing in veterans with TRD.ClinicalTrials.gov Identifier: NCT04469322.